Uncategorized
VEGF inhibitors for macular degeneration not tied to stroke
NEW YORK (Reuters Health) - Vascular endothelial growth factor (VEGF) inhibitors used for age-related
macular degeneration did not increase patients' risk of stroke in a population-based study in Canada.